Trial intelligence / Profile preview

Remifentanil for pain relief during neonatal central venous catheter insertion

ACTRN12612000385842Phase 2Recruiting

Sponsor
Dr Susan M Lord
Start
Jul 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of remifentanil in procedural pain (2 arms), sponsored by Dr Susan M Lord. Primary endpoint: Pain during central venous catheter insertion. Started Jul 2009; status: recruiting.

02

Drugs

remifentanil
03

Conditions

procedural pain

Beyond the preview

Go deeper on ACTRN12612000385842.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612000385842.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call